 | • レポートコード：QY2207C3840 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のグルコベイの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にグルコベイの世界市場のxxx％を占める「経口アカルボース」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のグルコベイの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのグルコベイ市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのグルコベイ市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 グルコベイのグローバル主要メーカーには、Bayer、CKDBioCorporation、Hangzhou East China Pharmaceutical、Livzon Pharmaceutical Group、Merck、Zhejiang Hisun Pharmaceutical、Healing Pharma、Strides Pharma、Morningsede Pharmaceuticals、Tevaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 グルコベイ市場は、種類と用途によって区分されます。世界のグルコベイ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 経口アカルボース、注射用アカルボース、冷凍乾燥粉末 【用途別セグメント】 病院、薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - グルコベイ製品概要 - 種類別市場（経口アカルボース、注射用アカルボース、冷凍乾燥粉末） - 用途別市場（病院、薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のグルコベイ販売量予測2017-2028 - 世界のグルコベイ売上予測2017-2028 - グルコベイの地域別販売量 - グルコベイの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別グルコベイ販売量 - 主要メーカー別グルコベイ売上 - 主要メーカー別グルコベイ価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（経口アカルボース、注射用アカルボース、冷凍乾燥粉末） - グルコベイの種類別販売量 - グルコベイの種類別売上 - グルコベイの種類別価格 ・用途別市場規模（病院、薬局、その他） - グルコベイの用途別販売量 - グルコベイの用途別売上 - グルコベイの用途別価格 ・北米市場 - 北米のグルコベイ市場規模（種類別、用途別） - 主要国別のグルコベイ市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのグルコベイ市場規模（種類別、用途別） - 主要国別のグルコベイ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のグルコベイ市場規模（種類別、用途別） - 主要国別のグルコベイ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のグルコベイ市場規模（種類別、用途別） - 主要国別のグルコベイ市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのグルコベイ市場規模（種類別、用途別） - 主要国別のグルコベイ市場規模（トルコ、サウジアラビア） ・企業情報 Bayer、CKDBioCorporation、Hangzhou East China Pharmaceutical、Livzon Pharmaceutical Group、Merck、Zhejiang Hisun Pharmaceutical、Healing Pharma、Strides Pharma、Morningsede Pharmaceuticals、Teva ・産業チェーン及び販売チャネル分析 - グルコベイの産業チェーン分析 - グルコベイの原材料 - グルコベイの生産プロセス - グルコベイの販売及びマーケティング - グルコベイの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - グルコベイの産業動向 - グルコベイのマーケットドライバー - グルコベイの課題 - グルコベイの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Glucobay Market
Due to the COVID-19 pandemic, the global Glucobay market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Oral Acarbose accounting for % of the Glucobay global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Glucobay market size is valued at US$ million in 2021, while the US and Europe Glucobay are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Glucobay landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Glucobay include Bayer, CKDBioCorporation, Hangzhou East China Pharmaceutical, Livzon Pharmaceutical Group, Merck, Zhejiang Hisun Pharmaceutical, Healing Pharma, Strides Pharma and Morningsede Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Glucobay Scope and Segment
Glucobay market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Glucobay market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Oral Acarbose
Injection Acarbose
Freeze-dried Powder
Segment by Application
Hospitals
Pharmacy
Others
By Company
Bayer
CKDBioCorporation
Hangzhou East China Pharmaceutical
Livzon Pharmaceutical Group
Merck
Zhejiang Hisun Pharmaceutical
Healing Pharma
Strides Pharma
Morningsede Pharmaceuticals
Teva
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Glucobay Product Introduction
1.2 Market by Type
1.2.1 Global Glucobay Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Acarbose
1.2.3 Injection Acarbose
1.2.4 Freeze-dried Powder
1.3 Market by Application
1.3.1 Global Glucobay Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Glucobay Sales Estimates and Forecasts 2017-2028
2.2 Global Glucobay Revenue Estimates and Forecasts 2017-2028
2.3 Global Glucobay Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Glucobay Sales by Region
2.4.1 Global Glucobay Sales by Region (2017-2022)
2.4.2 Global Sales Glucobay by Region (2023-2028)
2.5 Global Glucobay Revenue by Region
2.5.1 Global Glucobay Revenue by Region (2017-2022)
2.5.2 Global Glucobay Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Glucobay Sales by Manufacturers
3.1.1 Global Top Glucobay Manufacturers by Sales (2017-2022)
3.1.2 Global Glucobay Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Glucobay in 2021
3.2 Global Glucobay Revenue by Manufacturers
3.2.1 Global Glucobay Revenue by Manufacturers (2017-2022)
3.2.2 Global Glucobay Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Glucobay Revenue in 2021
3.3 Global Glucobay Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Glucobay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Glucobay Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Glucobay Sales by Type
4.1.1 Global Glucobay Historical Sales by Type (2017-2022)
4.1.2 Global Glucobay Forecasted Sales by Type (2023-2028)
4.1.3 Global Glucobay Sales Market Share by Type (2017-2028)
4.2 Global Glucobay Revenue by Type
4.2.1 Global Glucobay Historical Revenue by Type (2017-2022)
4.2.2 Global Glucobay Forecasted Revenue by Type (2023-2028)
4.2.3 Global Glucobay Revenue Market Share by Type (2017-2028)
4.3 Global Glucobay Price by Type
4.3.1 Global Glucobay Price by Type (2017-2022)
4.3.2 Global Glucobay Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Glucobay Sales by Application
5.1.1 Global Glucobay Historical Sales by Application (2017-2022)
5.1.2 Global Glucobay Forecasted Sales by Application (2023-2028)
5.1.3 Global Glucobay Sales Market Share by Application (2017-2028)
5.2 Global Glucobay Revenue by Application
5.2.1 Global Glucobay Historical Revenue by Application (2017-2022)
5.2.2 Global Glucobay Forecasted Revenue by Application (2023-2028)
5.2.3 Global Glucobay Revenue Market Share by Application (2017-2028)
5.3 Global Glucobay Price by Application
5.3.1 Global Glucobay Price by Application (2017-2022)
5.3.2 Global Glucobay Price Forecast by Application (2023-2028)
6 North America
6.1 North America Glucobay Market Size by Type
6.1.1 North America Glucobay Sales by Type (2017-2028)
6.1.2 North America Glucobay Revenue by Type (2017-2028)
6.2 North America Glucobay Market Size by Application
6.2.1 North America Glucobay Sales by Application (2017-2028)
6.2.2 North America Glucobay Revenue by Application (2017-2028)
6.3 North America Glucobay Market Size by Country
6.3.1 North America Glucobay Sales by Country (2017-2028)
6.3.2 North America Glucobay Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Glucobay Market Size by Type
7.1.1 Europe Glucobay Sales by Type (2017-2028)
7.1.2 Europe Glucobay Revenue by Type (2017-2028)
7.2 Europe Glucobay Market Size by Application
7.2.1 Europe Glucobay Sales by Application (2017-2028)
7.2.2 Europe Glucobay Revenue by Application (2017-2028)
7.3 Europe Glucobay Market Size by Country
7.3.1 Europe Glucobay Sales by Country (2017-2028)
7.3.2 Europe Glucobay Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Glucobay Market Size by Type
8.1.1 Asia Pacific Glucobay Sales by Type (2017-2028)
8.1.2 Asia Pacific Glucobay Revenue by Type (2017-2028)
8.2 Asia Pacific Glucobay Market Size by Application
8.2.1 Asia Pacific Glucobay Sales by Application (2017-2028)
8.2.2 Asia Pacific Glucobay Revenue by Application (2017-2028)
8.3 Asia Pacific Glucobay Market Size by Region
8.3.1 Asia Pacific Glucobay Sales by Region (2017-2028)
8.3.2 Asia Pacific Glucobay Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Glucobay Market Size by Type
9.1.1 Latin America Glucobay Sales by Type (2017-2028)
9.1.2 Latin America Glucobay Revenue by Type (2017-2028)
9.2 Latin America Glucobay Market Size by Application
9.2.1 Latin America Glucobay Sales by Application (2017-2028)
9.2.2 Latin America Glucobay Revenue by Application (2017-2028)
9.3 Latin America Glucobay Market Size by Country
9.3.1 Latin America Glucobay Sales by Country (2017-2028)
9.3.2 Latin America Glucobay Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Glucobay Market Size by Type
10.1.1 Middle East and Africa Glucobay Sales by Type (2017-2028)
10.1.2 Middle East and Africa Glucobay Revenue by Type (2017-2028)
10.2 Middle East and Africa Glucobay Market Size by Application
10.2.1 Middle East and Africa Glucobay Sales by Application (2017-2028)
10.2.2 Middle East and Africa Glucobay Revenue by Application (2017-2028)
10.3 Middle East and Africa Glucobay Market Size by Country
10.3.1 Middle East and Africa Glucobay Sales by Country (2017-2028)
10.3.2 Middle East and Africa Glucobay Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Glucobay Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Glucobay Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 CKDBioCorporation
11.2.1 CKDBioCorporation Corporation Information
11.2.2 CKDBioCorporation Overview
11.2.3 CKDBioCorporation Glucobay Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CKDBioCorporation Glucobay Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CKDBioCorporation Recent Developments
11.3 Hangzhou East China Pharmaceutical
11.3.1 Hangzhou East China Pharmaceutical Corporation Information
11.3.2 Hangzhou East China Pharmaceutical Overview
11.3.3 Hangzhou East China Pharmaceutical Glucobay Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Hangzhou East China Pharmaceutical Glucobay Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Hangzhou East China Pharmaceutical Recent Developments
11.4 Livzon Pharmaceutical Group
11.4.1 Livzon Pharmaceutical Group Corporation Information
11.4.2 Livzon Pharmaceutical Group Overview
11.4.3 Livzon Pharmaceutical Group Glucobay Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Livzon Pharmaceutical Group Glucobay Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Livzon Pharmaceutical Group Recent Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Overview
11.5.3 Merck Glucobay Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merck Glucobay Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck Recent Developments
11.6 Zhejiang Hisun Pharmaceutical
11.6.1 Zhejiang Hisun Pharmaceutical Corporation Information
11.6.2 Zhejiang Hisun Pharmaceutical Overview
11.6.3 Zhejiang Hisun Pharmaceutical Glucobay Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Zhejiang Hisun Pharmaceutical Glucobay Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Zhejiang Hisun Pharmaceutical Recent Developments
11.7 Healing Pharma
11.7.1 Healing Pharma Corporation Information
11.7.2 Healing Pharma Overview
11.7.3 Healing Pharma Glucobay Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Healing Pharma Glucobay Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Healing Pharma Recent Developments
11.8 Strides Pharma
11.8.1 Strides Pharma Corporation Information
11.8.2 Strides Pharma Overview
11.8.3 Strides Pharma Glucobay Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Strides Pharma Glucobay Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Strides Pharma Recent Developments
11.9 Morningsede Pharmaceuticals
11.9.1 Morningsede Pharmaceuticals Corporation Information
11.9.2 Morningsede Pharmaceuticals Overview
11.9.3 Morningsede Pharmaceuticals Glucobay Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Morningsede Pharmaceuticals Glucobay Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Morningsede Pharmaceuticals Recent Developments
11.10 Teva
11.10.1 Teva Corporation Information
11.10.2 Teva Overview
11.10.3 Teva Glucobay Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Teva Glucobay Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Glucobay Industry Chain Analysis
12.2 Glucobay Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Glucobay Production Mode & Process
12.4 Glucobay Sales and Marketing
12.4.1 Glucobay Sales Channels
12.4.2 Glucobay Distributors
12.5 Glucobay Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Glucobay Industry Trends
13.2 Glucobay Market Drivers
13.3 Glucobay Market Challenges
13.4 Glucobay Market Restraints
14 Key Findings in The Global Glucobay Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer